GUIDED THERAPEUTICS INC

CIK: 924515 SIC: 3845

Profile Charts Filings

$767.00K

Revenue

$-2.77M

Net Income

74.58%

Gross Margin

-309.26%

Op. Margin

$-1.90M

Free Cash Flow

Financial Statements Annual (10-K)

Showing 10 of 14 annual reports available (2011 - 2025)

Show: 5 10 All (14)

Annual Quarterly

Breakdown	TTM (Dec 31, 2025)	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2018 (Dec 31, 2018)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)
+ Total Revenue	$767.00K	$767.00K	$7.00K	$98.00K	$13.00K	$81.00K	$102.00K	$36.00K	$57.00K	-	$42.00K
Revenue Growth %	0.0%	10857.1%	-92.9%	653.8%	-84.0%	-20.6%	183.3%	-36.8%	nan%	-100.0%	nan%
Cost of Revenue	$195.00K	$196.00K	$5.00K	$62.00K	$81.00K	$61.00K	$-41.00K	$70.00K	$89.00K	$493.00K	$537.00K
+ Gross Profit	$572.00K	$571.00K	$2.00K	$36.00K	$-68.00K	$20.00K	$143.00K	$-34.00K	$-32.00K	$112.00K	$27.00K
Gross Margin %	74.6%	74.4%	28.6%	36.7%	-523.1%	24.7%	140.2%	-94.4%	-56.1%	nan%	64.3%
Operating Expenses	$2.94M	$2.94M	$2.11M	$3.49M	$3.27M	$2.38M	$1.20M	$903.00K	$1.52M	$3.93M	$6.30M
Research & Development	$470.00K	$469.00K	$526.00K	$228.00K	$77.00K	$69.00K	$143.00K	$122.00K	$244.00K	$733.00K	$1.48M
+ Operating Income	$-2.37M	$-2.37M	$-2.11M	$-3.46M	$-3.33M	$-2.36M	$-1.05M	$-937.00K	$-1.55M	$-3.82M	$-6.23M
Operating Margin %	-309.3%	-309.3%	-30114.3%	-3527.6%	-25638.5%	-2916.0%	-1031.4%	-2602.8%	-2715.8%	nan%	-14826.2%
Interest Expense	$617.00K	$617.00K	$381.00K	$278.00K	$582.00K	$1.15M	$1.06M	$1.41M	$1.76M	$1.90M	$1.32M
Other Income/Expense	$-603.00K	$-824.00K	$18.00K	$39.00K	$-1.01M	$292.00K	$773.00K	$-984.00K	$2.56M	$-150.00K	$-675.00K
Income Before Tax	$-3.20M	$-3.20M	$-2.42M	$-3.49M	$-4.34M	$-2.07M	$-279.00K	$-1.92M	$1.02M	$-3.97M	$-6.90M
Income Tax Expense	-	-	-	-	-	-	-	-	-	-	-
+ Net Income	$-2.77M	$-3.20M	$-2.42M	$-3.49M	$-4.34M	$-2.07M	$-279.00K	$-1.92M	$1.02M	$-3.97M	$-6.90M
Net Margin %	-361.3%	-416.7%	-34528.6%	-3560.2%	-33392.3%	-2555.6%	-273.5%	-5336.1%	1782.5%	nan%	-16433.3%
Basic EPS	nan	-0.04	-0.05	-0.07	-0.15	-0.18	-0.04	-0.58	1.95	nan	nan
Diluted EPS	nan	-0.04	-0.05	-0.07	-0.15	-0.18	-0.04	-0.58	0.01	nan	nan
Basic Shares Outstanding	2.1M	78.4M	57.3M	-	32.5M	13.4M	10.8M	3K	462	203	1K
Diluted Shares Outstanding	2.1M	78.4M	57.3M	51.1M	32.5M	13.4M	11K	3K	65K	-	-

Breakdown	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2018 (Dec 31, 2018)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)
Cash & Cash Equivalents	-	-	-	$2.31M	$643.00K	$182.00K	$899.00K	-	$14.00K	$35.00K
Accounts Receivable	$4.00K	$3.00K	$7.00K	$6.00K	$46.00K	$24.00K	$13.00K	$13.00K	-	$190.00K
Inventory	$448.00K	$633.00K	$632.00K	$548.00K	$571.00K	$605.00K	$48.00K	$114.00K	-	-
Other Current Assets	$90.00K	$173.00K	$163.00K	$137.00K	$377.00K	$85.00K	$70.00K	$69.00K	$259.00K	$780.00K
Total Current Assets	$605.00K	$1.20M	$1.39M	$3.00M	$1.64M	$896.00K	$1.03M	$196.00K	$1.05M	$2.12M
Property Plant & Equipment	$16.00K	$23.00K	$32.00K	$42.00K	$14.00K	$1.00K	-	$21.00K	$126.00K	$318.00K
Other Non-current Assets	$17.00K	$17.00K	$17.00K	$17.00K	$17.00K	-	$18.00K	-	-	-
Total Assets	$1.32M	$1.38M	$1.67M	$3.37M	$2.04M	$1.35M	$1.18M	$236.00K	$1.49M	$2.56M
Accounts Payable	$2.42M	$2.09M	$1.99M	$2.19M	$2.36M	$2.42M	$2.90M	$3.01M	$2.60M	$1.82M
Short-term Debt	-	-	-	-	-	-	$646.00K	$700.00K	$1.01M	$133.00K
Accrued Liabilities	$1.72M	$1.01M	$970.00K	$1.25M	$1.77M	$3.00M	$3.23M	$3.16M	$2.67M	$1.91M
Deferred Revenue	$189.00K	$849.00K	$424.00K	$509.00K	$337.00K	$42.00K	$101.00K	-	-	-
Total Current Liabilities	$6.64M	$6.16M	$4.81M	$4.87M	$5.69M	$8.96M	$12.41M	$10.99M	$9.34M	$5.52M
Long-term Debt	-	-	-	-	$820.00K	$23.00K	$5.71M	$5.07M	-	-
Total Liabilities	$7.33M	$6.27M	$5.47M	$6.25M	$7.49M	$12.21M	$18.11M	$16.06M	$10.76M	$8.12M
Common Stock	$3.47M	$3.45M	$3.44M	$3.44M	$3.40M	$3.40M	$3.39M	$2.88M	$742.00K	$236.00K
Retained Earnings	$-157.06M	$-153.71M	$-151.12M	$-147.36M	$-142.39M	$-139.96M	$-139.56M	$-137.63M	$-127.56M	$-122.56M
Treasury Stock	-	$132.00K	$132.00K	$132.00K	$132.00K	$132.00K	$132.00K	$132.00K	$132.00K	$132.00K
Total Stockholders Equity	$-6.01M	$-4.89M	$-3.81M	$-2.88M	$-5.45M	$-10.86M	$-16.93M	$-15.82M	$-9.27M	$-5.56M
Total Liabilities & Equity	$1.32M	$1.38M	$1.67M	$3.37M	$2.04M	$1.35M	$1.18M	$236.00K	$1.49M	$2.56M

Breakdown	TTM (Dec 31, 2025)	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2018 (Dec 31, 2018)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)
Net Income	$-2.77M	$-3.20M	$-2.42M	$-3.49M	$-4.34M	$-2.07M	$-279.00K	$-1.92M	$1.02M	$-3.97M	$-6.90M
Depreciation & Amortization	-	-	-	-	-	-	-	$21.00K	$27.00K	$1.22M	$1.05M
Stock-based Compensation	$707.02K	$377.00K	$120.00K	$1.81M	$176.00K	$228.00K	$310.00K	$8.00K	$44.00K	$95.00K	$1.01M
Deferred Income Tax	-	-	-	-	-	-	-	-	-	-	-
Change in Receivables	$13.00K	$7.00K	$-6.00K	$3.00K	$-16.00K	$22.00K	$23.00K	-	$10.00K	$31.00K	$-129.00K
Change in Inventory	$-223.00K	$-185.00K	$1.00K	$84.00K	$58.00K	$-33.00K	$483.00K	$-66.00K	$-151.00K	$-345.00K	$-61.00K
Change in Payables	-	-	-	-	-	-	$-372.00K	$20.00K	$-6.00K	$775.00K	$91.00K
Operating Cash Flow	$-1.90M	$-1.07M	$-1.12M	$-1.75M	$-1.48M	$-1.59M	$-1.88M	$-806.00K	$-1.36M	-	-
Capital Expenditure	-	$2.00K	-	-	$31.00K	$14.00K	$1.00K	-	-	-	$8.00K
Investing Cash Flow	-	$-2.00K	-	-	$-31.00K	$-14.00K	$-1.00K	-	-	-	$-8.00K
Stock Issued	-	$567.00K	$835.00K	-	$1.39M	-	-	-	$44.00K	$50.00K	$720.00K
Financing Cash Flow	$1.10M	$745.00K	$916.00K	$24.00K	$3.18M	$2.07M	$1.16M	$1.71M	$1.36M	$1.78M	$3.92M
Net Change in Cash	-	-	$-203.00K	$-1.72M	-	$461.00K	$-717.00K	$899.00K	$-1.00K	$-21.00K	$-127.00K

SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025

Condensed Consolidated Statements of Operations

Description	Sep 30, 2025		Sep 30, 2025
Description	Current	Prior Year	Current YTD	Prior Year YTD
Total Revenue	$60.00K	-	$177.00K	$6.00K
Cost of Revenue	$25.00K	-	$64.00K	$2.00K
Gross Profit	$35.00K	-	$113.00K	$4.00K
Operating Expenses	$520.00K	$561.00K	$1.77M	$1.58M
Research & Development	$136.00K	$111.00K	$342.00K	$386.00K
Operating Income	$-485.00K	$-561.00K	$-1.66M	$-1.57M
Interest Expense	$129.00K	$108.00K	$433.00K	$247.00K
Other Income/Expense	$-257.00K	$-93.00K	$-316.00K	$-191.00K
Income Before Tax	$-742.00K	$-654.00K	$-1.98M	$-1.76M
Income Tax Expense	-	-	-	-
Net Income	$-742.00K	$-654.00K	$-1.98M	$-1.76M
Basic EPS	-0.01	-0.01	-0.03	-0.03
Diluted EPS	-0.01	-0.01	-0.03	-0.03
Basic Shares Outstanding	$81.69M	$57.04M	$76.35M	$55.93M
Diluted Shares Outstanding	$81.69M	$57.04M	$76.35M	$55.93M

Condensed Consolidated Balance Sheets

Description	Sep 30, 2025	Dec 31, 2024
Accounts Receivable	$6.00K	$3.00K
Inventory	$583.00K	$633.00K
Other Current Assets	$123.00K	$173.00K
Total Current Assets	$799.00K	$1.20M
Property Plant & Equipment	$18.00K	$23.00K
Other Non-current Assets	$17.00K	$17.00K
Total Assets	$903.00K	$1.38M
Accounts Payable	$2.38M	$2.09M
Accrued Liabilities	$952.00K	$1.01M
Deferred Revenue	$689.00K	$849.00K
Total Current Liabilities	$6.47M	$6.16M
Total Liabilities	$6.55M	$6.27M
Common Stock	$3.47M	$3.45M
Retained Earnings	$-155.81M	$-153.71M
Total Stockholders Equity	$-5.65M	$-4.89M
Total Liabilities & Equity	$903.00K	$1.38M

Condensed Consolidated Statements of Cash Flows

Description	Sep 30, 2025		Sep 30, 2025
Description	Current	Prior Year	Current YTD	Prior Year YTD
Net Income	$-742.00K	$-654.00K	$-1.98M	$-1.76M
Stock-based Compensation	-	-	$352.00K	$133.00K
Change in Receivables	-	-	$7.00K	$-4.00K
Change in Inventory	-	-	$-50.00K	$4.00K
Operating Cash Flow	-	-	$-777.00K	$-787.00K
Capital Expenditure	-	-	$2.00K	-
Investing Cash Flow	-	-	$-2.00K	-
Financing Cash Flow	-	-	$478.00K	$390.00K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.